StonvexLoading…
StonvexStonvexStonvexCore line items from SAM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $579.97M | $461.58M | $2.09B | $1.68B | $1.11B |
Operating Income | Not available | $-190.46M | $144.88M | $177.90M | $115.84M |
Net Income | Not available | $-145.26M | $108.47M | $131.00M | $60.43M |
EPS (Diluted) | $5.01 | $-13.88 | $9.89 | $11.82 | $7.58 |
Total Assets | Not available | $1.17B | $1.19B | $1.25B | $1.27B |
Total Liabilities | Not available | $488.45M | $347.31M | $335.62M | $355.87M |
Cash & Equivalents | Not available | $164.12M | $223.38M | $250.45M | $212.43M |
Free Cash Flow OCF − CapEx | Not available | $-32.76M | $215.59M | $193.50M | $104.26M |
Shares Outstanding | Not available | 10.47M | 10.94M | 11.05M | 11.16M |